MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Precipio Total Non Current Liabilities 2011-2026 | PRPO
Annual Total Non Current Liabilities Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.9 M | 1.97 M | 1.72 M | 4.2 M | 785 K | 655 K | 12.3 M | 10.2 M | 1.99 M | 6.19 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.3 M | 655 K | 4.19 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
3.29 B | $ 111.3 | -3.12 % | $ 33.8 B |  USA |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 25.58 | -5.68 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 20.8 | -5.07 % | $ 1.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
574 K | $ 1.53 | -6.13 % | $ 2.04 M | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 24.24 | -1.86 % | $ 673 M | USA |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 163.84 | -1.77 % | $ 8.12 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
91.4 M | $ 83.41 | 0.35 % | $ 10.5 B | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 14.8 | -3.27 % | $ 447 M | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.99 | 2.9 % | $ 8.8 M | USA |
 |
Illumina
ILMN
|
2.04 B | $ 120.37 | -5.16 % | $ 19.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
1.57 M | $ 2.16 | -1.22 % | $ 4.96 M | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 81.17 | -2.85 % | $ 5.48 B | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 116.17 | 13.35 % | $ 9.58 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 257.14 | -0.94 % | $ 21.4 B | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 413.59 | 0.93 % | $ 11.9 B | USA |
 |
Celcuity
CELC
|
69.2 K | $ 119.0 | -0.89 % | $ 5.56 B | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
NeoGenomics
NEO
|
435 M | $ 8.96 | -0.67 % | $ 1.15 B | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 9.01 | -3.53 % | $ 1.95 B | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 16.54 | -1.78 % | $ 370 M | USA |
 |
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | USA |
 |
Myriad Genetics
MYGN
|
107 M | $ 4.68 | -3.31 % | $ 433 M | USA |
 |
OpGen
OPGN
|
21.2 M | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
124 M | $ 194.75 | -2.71 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 189.32 | -2.94 % | $ 21 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 16.24 | -2.46 % | $ 175 M | China |
 |
Organovo Holdings
ONVO
|
588 K | - | -2.3 % | $ 19.4 M | USA |
 |
PerkinElmer
PKI
|
2.96 B | - | -0.91 % | $ 14.7 B | USA |
 |
Personalis
PSNL
|
639 K | $ 5.04 | -8.36 % | $ 299 M | USA |
 |
Exagen
XGN
|
27.8 M | $ 2.76 | 1.1 % | $ 59.5 M | USA |